Cargando…

RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China

This review summarizes the history, function, application, and achievement of the RheumCloud App as a novel smartphone application. This App reflects the development of the Chinese Rheumatism Data Center (CRDC), which provides not only a technical platform for the database and registry of rheumatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Can, Zhao, Jiuliang, Tian, Xinping, Wang, Qian, Xu, Dong, Li, Mengtao, Zeng, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984926/
https://www.ncbi.nlm.nih.gov/pubmed/36879841
http://dx.doi.org/10.2478/rir-2022-0033
_version_ 1784900841076948992
author Huang, Can
Zhao, Jiuliang
Tian, Xinping
Wang, Qian
Xu, Dong
Li, Mengtao
Zeng, Xiaofeng
author_facet Huang, Can
Zhao, Jiuliang
Tian, Xinping
Wang, Qian
Xu, Dong
Li, Mengtao
Zeng, Xiaofeng
author_sort Huang, Can
collection PubMed
description This review summarizes the history, function, application, and achievement of the RheumCloud App as a novel smartphone application. This App reflects the development of the Chinese Rheumatism Data Center (CRDC), which provides not only a technical platform for the database and registry of rheumatic diseases (RDs) in China, but also a close tie between Chinese rheumatologists and patients with RDs. Throughout the past decade, CRDC has successfully built the world’s largest nationwide database for RDs. A total of 2074 tertiary referral centers consisting of 8051 rheumatologists participated in the registry. RheumCloud App, which is representative of the success of CRDC, has played a central role in supporting patient cohort registration, biosample collection, and patient education. Based on the data of the Rhuem-Cloud App, three national key research projects have been funded and a series of research papers have been published.
format Online
Article
Text
id pubmed-9984926
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-99849262023-03-05 RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China Huang, Can Zhao, Jiuliang Tian, Xinping Wang, Qian Xu, Dong Li, Mengtao Zeng, Xiaofeng Rheumatol Immunol Res Communication This review summarizes the history, function, application, and achievement of the RheumCloud App as a novel smartphone application. This App reflects the development of the Chinese Rheumatism Data Center (CRDC), which provides not only a technical platform for the database and registry of rheumatic diseases (RDs) in China, but also a close tie between Chinese rheumatologists and patients with RDs. Throughout the past decade, CRDC has successfully built the world’s largest nationwide database for RDs. A total of 2074 tertiary referral centers consisting of 8051 rheumatologists participated in the registry. RheumCloud App, which is representative of the success of CRDC, has played a central role in supporting patient cohort registration, biosample collection, and patient education. Based on the data of the Rhuem-Cloud App, three national key research projects have been funded and a series of research papers have been published. Sciendo 2022-12-31 /pmc/articles/PMC9984926/ /pubmed/36879841 http://dx.doi.org/10.2478/rir-2022-0033 Text en © 2022 Can Huang, Jiuliang Zhao, Xinping Tian, Qian Wang, Dong Xu, Mengtao Li, Xiaofeng Zeng, published by De Gruyter https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Communication
Huang, Can
Zhao, Jiuliang
Tian, Xinping
Wang, Qian
Xu, Dong
Li, Mengtao
Zeng, Xiaofeng
RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China
title RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China
title_full RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China
title_fullStr RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China
title_full_unstemmed RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China
title_short RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China
title_sort rheumcloud app: a novel mobile application for the management of rheumatic diseases patients in china
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984926/
https://www.ncbi.nlm.nih.gov/pubmed/36879841
http://dx.doi.org/10.2478/rir-2022-0033
work_keys_str_mv AT huangcan rheumcloudappanovelmobileapplicationforthemanagementofrheumaticdiseasespatientsinchina
AT zhaojiuliang rheumcloudappanovelmobileapplicationforthemanagementofrheumaticdiseasespatientsinchina
AT tianxinping rheumcloudappanovelmobileapplicationforthemanagementofrheumaticdiseasespatientsinchina
AT wangqian rheumcloudappanovelmobileapplicationforthemanagementofrheumaticdiseasespatientsinchina
AT xudong rheumcloudappanovelmobileapplicationforthemanagementofrheumaticdiseasespatientsinchina
AT limengtao rheumcloudappanovelmobileapplicationforthemanagementofrheumaticdiseasespatientsinchina
AT zengxiaofeng rheumcloudappanovelmobileapplicationforthemanagementofrheumaticdiseasespatientsinchina